Literature summary for 2.7.1.21 extracted from

Jagarlamudi, K.K.; Westberg, S.; Roennberg, H.; Eriksson, S.
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker (2014), BMC Vet. Res., 10, 228.

Search for more literature for 2.7.1.21

Application

Application	Comment	Organism
medicine	serum TK1 protein and activity levels are significantly higher in canine mammary tumor than in healthy dogs. Major differences are found in the molecular forms of TK1 in acute lymphocytic leukemia, healthy, and in canine mammary tumor dogs, with a large fraction of inactive TK1 protein in in canine mammary tumor dogs. The serum TK1 protein assay can differentiate benign tumors (early stage tumors) from healthy more efficiently than the serum TK1 activity assay	Canis lupus familiaris

Organism

Organism	UniProt	Comment	Textmining
Canis lupus familiaris	E2QXP4	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)